Skip to content
10-K

Annual Report

AMERICAN ORIENTAL BIOENGINEERING INC

0001019687-13-000061

← back to feed
Filed
Jan 7, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Dec 14, 2012 36.42M sh
Stockholders Equity FY 2011 · Dec 31, 2010 $428.07M
Current Liabilities FY 2011 · Dec 31, 2010 $44.08M
Total Liabilities FY 2011 · Dec 31, 2010 $181.65M
Current Assets FY 2011 · Dec 31, 2010 $244.63M
Total Assets FY 2011 · Dec 31, 2010 $610.22M
Shares Diluted FY 2011 · Dec 31, 2009 44.64M sh
Capex FY 2011 · Dec 31, 2009 $3.98M
Operating Cash Flow FY 2011 · Dec 31, 2009 $27.57M
Eps Diluted FY 2011 · Dec 31, 2009 $1.06
Eps Basic FY 2011 · Dec 31, 2009 $1.11
Sga Expense FY 2011 · Dec 31, 2009 $62.16M
Rd Expense FY 2011 · Dec 31, 2009 $7.92M
Net Income FY 2011 · Dec 31, 2009 $41.42M
Operating Income FY 2011 · Dec 31, 2009 $58.76M
Gross Profit FY 2011 · Dec 31, 2009 $166.78M
Cost Of Revenue FY 2011 · Dec 31, 2009 $129.37M
Revenue FY 2011 · Dec 31, 2009 $296.15M
Cash And Equivalents FY 2011 · Dec 31, 2008 $68.06M